TY - JOUR PY - 2017 DA - 2017// TI - Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study JO - Lancet Gastroenterol Hepatol VL - 2 UR - https://doi.org/10.1016/S2468-1253(16)30181-9 DO - 10.1016/S2468-1253(16)30181-9 ID - ref1 ER - TY - STD TI - WHO. Global hepatitis report 2017. World Health Organization; Geneva 2017. https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ UR - https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ ID - ref2 ER - TY - STD TI - WHO 2016. Combating hepatitis B and C to reach elimination by 2030 – advocacy brief. World Health Organization, Geneva May 2016. http://www.who.int/hepatitis/publications/hep-elimination-by-2030-brief/en/ UR - http://www.who.int/hepatitis/publications/hep-elimination-by-2030-brief/en/ ID - ref3 ER - TY - JOUR AU - Bajis, S. AU - Dore, G. J. AU - Hajarizadeh, B. AU - Cunningham, E. B. AU - Maher, L. AU - Grebely, J. PY - 2017 DA - 2017// TI - Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.07.002 DO - 10.1016/j.drugpo.2017.07.002 ID - Bajis2017 ER - TY - STD TI - World Health Organization Global Health Sector Strategy on Viral Hepatitis 2016-2021. Towards ending viral hepatitis. World Health Organization Geneva 2016 https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ UR - https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ ID - ref5 ER - TY - STD TI - Harris M, Rhodes. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors Harm Reduction Journal 2013 10, 7. doi: https://doi.org/10.1186/1477-7517-10-7. ID - ref6 ER - TY - JOUR AU - Jones, L. AU - Atkinson, A. AU - Bates, G. AU - McCoy, E. AU - Porcellato, L. AU - Beynon, C. PY - 2014 DA - 2014// TI - Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research JO - Int J Drug Policy VL - 25 UR - https://doi.org/10.1016/j.drugpo.2013.11.004 DO - 10.1016/j.drugpo.2013.11.004 ID - Jones2014 ER - TY - STD TI - Dowsett LE, Coward S, Lorenzetti DL, MacKean G, Clement F. Living with hepatitis C virus: a systematic review and narrative synthesis of qualitative literature. Can J Gastroenterol Hepatol. 2017. https://doi.org/10.1155/2017/3268650. ID - ref8 ER - TY - JOUR AU - Simmons, R. AU - Ireland, G. AU - Irving, W. AU - Hickman, M. AU - Sabin, C. AU - Ijaz, S. AU - Ramsay, M. AU - Lattimore, S. AU - Mandal, S. PY - 2018 DA - 2018// TI - Establishing the cascade of care for hepatitis C in England—benchmarking to monitor impact of direct acting antivirals JO - J Viral Hepat VL - 25 UR - https://doi.org/10.1111/jvh.12844 DO - 10.1111/jvh.12844 ID - Simmons2018 ER - TY - BOOK PY - 2016 DA - 2016// TI - Hepatitis C among drug users in Europe: epidemiology, treatment and prevention, EMCDDA insights 23 PB - Publications Office of the EU CY - Luxembourg ID - ref10 ER - TY - JOUR AU - Grebely, J. AU - Bruneau, J. AU - Bruggmann, P. AU - Harris, M. AU - Hickman, M. AU - Rhodes, T. AU - Treloar, C. PY - 2017 DA - 2017// TI - Elimination of hepatitis C virus infection among PWID: the beginning of a new era of interferon-free DAA therapy JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.08.001 DO - 10.1016/j.drugpo.2017.08.001 ID - Grebely2017 ER - TY - JOUR AU - Wade, A. J. AU - Veronese, V. AU - Hellard, M. E. AU - Doyle, J. S. PY - 2016 DA - 2016// TI - A systematic review of community based hepatitis C treatment JO - BMC Infect Dis VL - 16 UR - https://doi.org/10.1186/s12879-016-1548-5 DO - 10.1186/s12879-016-1548-5 ID - Wade2016 ER - TY - JOUR AU - Falade-Nwulia, O. AU - Suarez-Cuervo, C. AU - Nelson, D. R. AU - Fried, M. W. AU - Segal, J. D. AU - Sulkowski, M. S. PY - 2017 DA - 2017// TI - Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review JO - Ann Intern Med VL - 166 UR - https://doi.org/10.7326/M16-2575 DO - 10.7326/M16-2575 ID - Falade-Nwulia2017 ER - TY - STD TI - Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. Geneva: World Health Organization; 2018. https://apps.who.int/iris/bitstream/handle/10665/273174/9789241550345-eng.pdf?ua=1 UR - https://apps.who.int/iris/bitstream/handle/10665/273174/9789241550345-eng.pdf?ua=1 ID - ref14 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gøtzsche, P. C. AU - Ioannidis, J. P. A. AU - Clarke, M. AU - Devereaux, J. AU - Kleijnen, J. AU - Moher, D. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration JO - Br Med J VL - 339 UR - https://doi.org/10.1136/bmj.b2700 DO - 10.1136/bmj.b2700 ID - Liberati2009 ER - TY - JOUR AU - Emmanuel, B. AU - Wilson, E. M. AU - O'Brien, T. R. AU - Kottilil, S. AU - Lau, G. PY - 2017 DA - 2017// TI - Shortening the duration of therapy for chronic hepatitis C infection JO - Lancet Gastroenterol Hepatol VL - 2 UR - https://doi.org/10.1016/S2468-1253(17)30053-5 DO - 10.1016/S2468-1253(17)30053-5 ID - Emmanuel2017 ER - TY - STD TI - World Health Organisation. Main terminology – primary health care. http://www.euro.who.int/en/health-topics/Health-systems/primary-health-care/main-terminology (). UR - http://www.euro.who.int/en/health-topics/Health-systems/primary-health-care/main-terminology ID - ref17 ER - TY - STD TI - Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org. (). UR - http://handbook.cochrane.org ID - ref18 ER - TY - STD TI - Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (). UR - http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp ID - ref19 ER - TY - STD TI - Sabbagh HJ, Hassan M, Hassan A, Innes NP, Elkday HM, Little J, Massey PA. Passive smoking in the etiology of non-Syndromic Orofacial clefts: a systematic review and meta-analysis. PLoS One. 2015. https://doi.org/10.1371/journal.pone.0116963. ID - ref20 ER - TY - JOUR AU - Berkman, N. D. AU - Lohr, K. N. AU - Ansari, M. T. AU - Balk, E. M. AU - Kane, R. AU - McDonagh, M. AU - Morton, S. C. AU - Viswanathan, M. AU - Bass, E. B. AU - Butler, M. AU - Gartlehener, G. AU - Hartley, L. AU - McPheteers, M. AU - Morgan, L. C. AU - Reston, J. AU - Sista, P. AU - Whitlock, E. AU - Chang, S. PY - 2015 DA - 2015// TI - Grading the strength of a body of evidence when assessing health care interventions: an EPC update JO - J Clin Epidemiol VL - 68 UR - https://doi.org/10.1016/j.jclinepi.2014.11.023 DO - 10.1016/j.jclinepi.2014.11.023 ID - Berkman2015 ER - TY - STD TI - Bloom S, Lubel J, Nicoll A, Gow P, Dev A, Roberts S, Bell S, Kronberg I, Knight V, Sood S, Lewis D, Kemp W, On behalf of the Melbourne Liver Group. Comparison of direct-acting antiviral therapy for hepatitis C between specialist centres and primary care: efficacy and adherence to response assessment. J Gastroenterol Hepatol. 2017;32, 65(suppl 2). https://doi.org/10.1111/jgh.13892. ID - ref22 ER - TY - JOUR AU - Francheville, J. W. AU - Rankin, R. AU - Beck, J. AU - Hoare, C. AU - Materniak, S. AU - German, G. AU - Barrett, L. AU - Bunimov-Wall, N. AU - Smyth, D. PY - 2017 DA - 2017// TI - Early success in an open access provincially funded hepatitis C treatment program in Prince Edward Island JO - Ann Hepatol VL - 16 UR - https://doi.org/10.5604/01.3001.0010.2757 DO - 10.5604/01.3001.0010.2757 ID - Francheville2017 ER - TY - JOUR AU - Kattakuzhy, S. AU - Gross, C. AU - Emmanuel, B. AU - Teferi, G. AU - Jenkins, V. AU - Silk, R. AU - Akoth, E. AU - Thomas, A. AU - Ahmed, C. AU - Espinosa, M. AU - Price, A. AU - Rosenthal, E. AU - Tang, L. AU - Wilson, E. AU - Bentzen, S. AU - Masur, H. AU - Kottilil, S. PY - 2017 DA - 2017// TI - Expansion of treatment for hepatitis C virus infection by task shifting to community-based non-specialist providers: a nonrandomized clinical trial JO - Ann Inter Med VL - 167 UR - https://doi.org/10.7326/M17-0118 DO - 10.7326/M17-0118 ID - Kattakuzhy2017 ER - TY - STD TI - McClure T, Olenski M, Ward A, Glasgow S, Stothers L, New K, Papaluca T, Wong D, Burns G, Valaydon Z, Mei SCY, Jeremiah C, Visvanathan K, Croagh C, Howell J, Hong T, Ryan M, Demeduik B, Lust M, Shaw G, Iser D, Nguyen T, Desmond P, Bell S , Thompson AJ. Real-world treatment for hepatitis C in the direct acting antiviral era: Comparing outcomes between the tertiary liver clinic and community J Gastroenterol Hepatol 2017; 32: (suppl 2): 74. DOI:https://doi.org/10.1111/jgh.13892 ID - ref25 ER - TY - STD TI - Miller L, Quairoli K, Lom J, Fluker SA. Access to and success with new hepatitis c therapy in an urban primary care centre. J. General Internal Medicine 2016: 31 (2) 1: S110. 10.1007%2Fs11606-016-3657-7 UR - https://doi.org/10.1007/s11606-016-3657-7 ID - ref26 ER - TY - JOUR AU - Norton, B. L. AU - Fleming, J. AU - Bachhuber, M. A. AU - Steinman, M. AU - DeLuca, J. AU - Cunningham, C. O. AU - Johnson, N. AU - Laraque, F. AU - Litwin, A. H. PY - 2017 DA - 2017// TI - High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.07.021 DO - 10.1016/j.drugpo.2017.07.021 ID - Norton2017 ER - TY - STD TI - Wade AJ, Doyle JS, Gane E, Stedman C, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Thompson AJ, Hellard ME. Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs. Clin Infect Dis. 2019:ciz546. https://doi.org/10.1093/cid/ciz546. ID - ref28 ER - TY - STD TI - Abdulameer A, Leff P, Joshi K, Hepner A, Moore A, Arendt K, Reynolds J, Gish R, Manch R, Kohli A. Effectiveness of sofosbuvir/ledipasvir and sofosbuvir/ simeprevir for the treatment of hepatitis C genotype-1: Real world analysis. Hepatology 2016; 64 (1) S1: 989A-990A. ID - ref29 ER - TY - JOUR AU - Beste, L. A. AU - Glorioso, T. J. AU - Ho, P. M. AU - Au, D. H. AU - Kirsch, S. R. AU - Todd-Stenberg, J. AU - Chang, M. F. AU - Dominitz, J. A. AU - Baron, A. E. PY - 2017 DA - 2017// TI - Telemedicine speciality support promoites hepatitis C treatment by primary care providers in the department of vetrerans affairs JO - Am J Med VL - 130 UR - https://doi.org/10.1016/j.ammed.2016.11.019 DO - 10.1016/j.ammed.2016.11.019 ID - Beste2017 ER - TY - JOUR AU - Buchanan, R. AU - Shalabi, A. AU - Parkes, J. AU - Khakoo, S. PY - 2015 DA - 2015// TI - Hepatology outreach services to overcome inequalities in hepatitis C care in an isolated UK population (PTU 112) JO - Gut VL - 64 ID - Buchanan2015 ER - TY - JOUR AU - Georgie, F. AU - Nafisi, S. AU - Kohli, A. AU - Thornton, K. AU - Reynolds, J. AU - Moore, A. AU - Gish, R. AU - Scott, J. AU - Deming, P. AU - Sedillo, M. AU - Qualls, C. AU - Box, T. AU - Cox, P. AU - Mera, J. AU - Miller, A. AU - Sussman, N. AU - Khaderi, S. AU - Manch, R. AU - Arora, S. PY - 2016 DA - 2016// TI - Primary care physicians utilising the ECHO model equally effective as subspecialists treating HCV using direct-acting antivirals-only regimens: results of the ECHO model (SAT-260) JO - J Hepatol VL - 64 UR - https://doi.org/10.1016/S0168-8278(16)01600-7 DO - 10.1016/S0168-8278(16)01600-7 ID - Georgie2016 ER - TY - JOUR AU - Butner, J. L. AU - Gupta, N. AU - Fabian, C. AU - Henry, S. AU - Shi, J. M. AU - Tetrault, J. M. PY - 2017 DA - 2017// TI - Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program JO - J Subst Abus Treat VL - 75 UR - https://doi.org/10.1016/j.sat.2016.12.014 DO - 10.1016/j.sat.2016.12.014 ID - Butner2017 ER - TY - JOUR AU - Morris, L. AU - Smirnov, A. AU - Kvassay, A. AU - Leslie, E. AU - Kavanagh, R. AU - Alexander, N. AU - Davey, G. AU - Williams, O. AU - Gilks, C. AU - Najman, J. PY - 2017 DA - 2017// TI - Initial outcomes of integrated community-based hepatitis c treatment for people who inject drugs: findings from the Queensland injectors’ health network JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.05.056 DO - 10.1016/j.drugpo.2017.05.056 ID - Morris2017 ER - TY - JOUR AU - Read, P. AU - Lothian, R. AU - Chronister, K. AU - Gilliver, R. AU - Kearley, J. AU - Dore, G. J. AU - Beck, I. PY - 2017 DA - 2017// TI - Delivering direct acting antiviral therapy for hepatitis c to highly marginalised and current drug injecting populations in atargeted primary health care setting JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.05.032 DO - 10.1016/j.drugpo.2017.05.032 ID - Read2017 ER - TY - STD TI - David C, David D, Essex W, Deming P, Qualls CR, Mera J. Hepatitis c treatment outcomes in a pharmacist-managed clinic in a rural tribal health system. Hepatology 2017; 66 (s1): 331A. Poster 609. ID - ref36 ER - TY - JOUR AU - Radley, A. AU - Tait, J. AU - Dillon, J. F. PY - 2017 DA - 2017// TI - DOT-C: a cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitution therapy from a community pharmacy JO - Int J Drug Policy VL - 47 UR - https://doi.org/10.1016/j.drugpo.2017.05.042 DO - 10.1016/j.drugpo.2017.05.042 ID - Radley2017 ER - TY - JOUR AU - Cooper, C. L. AU - Hatashita, H. AU - Corsi, D. J. AU - Parmar, P. AU - Corrin, R. AU - Garber, G. PY - 2017 DA - 2017// TI - Direct-acting antiviral therapy outcomes in Canadian chronic hepatitis c telemedicine patients JO - Ann Hepatol VL - 16 UR - https://doi.org/10.5604/01.3001.0010.5277 DO - 10.5604/01.3001.0010.5277 ID - Cooper2017 ER - TY - STD TI - Ní Cheallaigh C, O’Leary A, Keating S, Singleton A, Heffernan S, Keenan E, Robson L, Sears J, Moloney J, Arora S, Bergin C, Norris S On behalf of the Irish Hepatitis C Outcomes Research Network. Telementoring with project ECHO: a pilot study in Europe. BMJ Innovations 2017;3:144–151. doi:https://doi.org/10.1136/bmjinnov-2016-000141. ID - ref39 ER - TY - STD TI - Shehata N, Austin T, Ha S, Timmerman K. Barriers and facilitators of hepatitis C virus screening and testing: a scoping review Canadian Communicable Diseases Reports 2018; 44:7–8. PMID:31011297 ID - ref40 ER - TY - JOUR AU - Aspinall, E. J. AU - Doyle, J. S. AU - Corson, S. AU - Hellard, M. E. AU - Hunt, D. AU - Goldberg, D. AU - Nguyen, T. AU - Ytter, Y. F. AU - Morgan, R. L. AU - Smith, B. AU - Stoove, M. AU - Wiktor, S. Z. AU - Hutchinson, S. PY - 2015 DA - 2015// TI - Targeted hepatitis C antibody testing interventions: a systematic review JO - Eur J Epidemiol VL - 30 UR - https://doi.org/10.1007/s10654-014-9958-4 DO - 10.1007/s10654-014-9958-4 ID - Aspinall2015 ER - TY - STD TI - McDermott CL; Lockhart CM, Devine B. Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis. J Virus Eradication 2018; 4 (2): 118–122. PMC5892673. ID - ref42 ER - TY - JOUR AU - Grebely, J. AU - Dore, G. J. AU - Morin, S. AU - Rockstroh, J. K. AU - Klein, M. B. PY - 2017 DA - 2017// TI - Elimination of HCV as a public health concern among people who inject drugs by 2030 - what will it take to get there? JO - J Int AIDS Soc VL - 20 UR - https://doi.org/10.7448/IAS.20.1.22146 DO - 10.7448/IAS.20.1.22146 ID - Grebely2017 ER - TY - STD TI - Wade AJ, McCormack A, Roder C, McDonald K, Davies M, Scott N, Wardrop M, AThan E, Hellard ME. Aiming for elimination: outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C. J Viral Hepat. 2018:1–10. https://doi.org/10.1111/jvh.12910. ID - ref44 ER - TY - STD TI - A de Bruin M, Inglis SK, Donnan PT, Dillon JF. Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for Hepatitis C in patients receiving opioid substitution therapy: A study protocol for “SuperDOT-C” –a pragmatic cluster randomised trial. BMJ Open 2018 DOI:https://doi.org/10.1136/bmjopen-2017-021443 ID - ref45 ER - TY - STD TI - Swan D, Cullen W, Macias J, Oprea C, Story A, Surey J, Vickerman P S. Lambert JS. Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol, Expert Review of Gastroenterology & Hepatology 2018, 12:3, 303–314, DOI: https://doi.org/10.1080/17474124.2018.1424541 ID - ref46 ER - TY - JOUR AU - Martin, N. K. AU - Vickerman, P. AU - Grebely, J. PY - 2013 DA - 2013// TI - Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals JO - Hepatology VL - 58 UR - https://doi.org/10.1002/hep.26431 DO - 10.1002/hep.26431 ID - Martin2013 ER -